Literature DB >> 26487690

Apparent diffusion coefficient histogram metrics correlate with survival in diffuse intrinsic pontine glioma: a report from the Pediatric Brain Tumor Consortium.

Tina Young Poussaint1, Sridhar Vajapeyam1, Kelsey I Ricci1, Ashok Panigrahy1, Mehmet Kocak1, Larry E Kun1, James M Boyett1, Ian F Pollack1, Maryam Fouladi1.   

Abstract

BACKGROUND: Diffuse intrinsic pontine glioma (DIPG) is associated with poor survival regardless of therapy. We used volumetric apparent diffusion coefficient (ADC) histogram metrics to determine associations with progression-free survival (PFS) and overall survival (OS) at baseline and after radiation therapy (RT).
METHODS: Baseline and post-RT quantitative ADC histograms were generated from fluid-attenuated inversion recovery (FLAIR) images and enhancement regions of interest. Metrics assessed included number of peaks (ie, unimodal or bimodal), mean and median ADC, standard deviation, mode, skewness, and kurtosis.
RESULTS: Based on FLAIR images, the majority of tumors had unimodal peaks with significantly shorter average survival. Pre-RT FLAIR mean, mode, and median values were significantly associated with decreased risk of progression; higher pre-RT ADC values had longer PFS on average. Pre-RT FLAIR skewness and standard deviation were significantly associated with increased risk of progression; higher pre-RT FLAIR skewness and standard deviation had shorter PFS. Nonenhancing tumors at baseline showed higher ADC FLAIR mean values, lower kurtosis, and higher PFS. For enhancing tumors at baseline, bimodal enhancement histograms had much worse PFS and OS than unimodal cases and significantly lower mean peak values. Enhancement in tumors only after RT led to significantly shorter PFS and OS than in patients with baseline or no baseline enhancement.
CONCLUSIONS: ADC histogram metrics in DIPG demonstrate significant correlations between diffusion metrics and survival, with lower diffusion values (increased cellularity), increased skewness, and enhancement associated with shorter survival, requiring future investigations in large DIPG clinical trials.
© The Author(s) 2015. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  ADC histogram; MR diffusion; brain tumor; brainstem glioma; pediatric

Mesh:

Year:  2015        PMID: 26487690      PMCID: PMC4827042          DOI: 10.1093/neuonc/nov256

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN: 1522-8517            Impact factor:   12.300


  32 in total

1.  Pediatric brainstem glioma. Post-radiation clinical and MR follow-up.

Authors:  R R Smith; R A Zimmerman; R J Packer; D B Hackney; L T Bilaniuk; L N Sutton; H I Goldberg; R I Grossman; L Schut
Journal:  Neuroradiology       Date:  1990       Impact factor: 2.804

2.  Recurrent glioblastoma multiforme: ADC histogram analysis predicts response to bevacizumab treatment.

Authors:  Whitney B Pope; Hyun J Kim; Jing Huo; Jeffry Alger; Matthew S Brown; David Gjertson; Victor Sai; Jonathan R Young; Leena Tekchandani; Timothy Cloughesy; Paul S Mischel; Albert Lai; Phioanh Nghiemphu; Syed Rahmanuddin; Jonathan Goldin
Journal:  Radiology       Date:  2009-07       Impact factor: 11.105

3.  Evaluation of 18F-FDG PET and MRI associations in pediatric diffuse intrinsic brain stem glioma: a report from the Pediatric Brain Tumor Consortium.

Authors:  Katherine A Zukotynski; Frederic H Fahey; Mehmet Kocak; Abass Alavi; Terence Z Wong; S Ted Treves; Barry L Shulkin; Daphne A Haas-Kogan; Jeffrey R Geyer; Sridhar Vajapeyam; James M Boyett; Larry E Kun; Tina Young Poussaint
Journal:  J Nucl Med       Date:  2011-01-13       Impact factor: 10.057

4.  Pediatric brain tumor consortium multisite assessment of apparent diffusion coefficient z-axis variation assessed with an ice-water phantom.

Authors:  Robert V Mulkern; Kelsey I Ricci; Sridhar Vajapeyam; Thomas L Chenevert; Dariya I Malyarenko; Mehmet Kocak; Tina Young Poussaint
Journal:  Acad Radiol       Date:  2014-11-27       Impact factor: 3.173

5.  MRI as a central component of clinical trials analysis in brainstem glioma: a report from the Pediatric Brain Tumor Consortium (PBTC).

Authors:  Tina Young Poussaint; Mehmet Kocak; Sridhar Vajapeyam; Roger I Packer; Richard L Robertson; Russell Geyer; Daphne Haas-Kogan; Ian F Pollack; Gilbert Vezina; Robert Zimmerman; Soonmee Cha; Zoltan Patay; James M Boyett; Larry E Kun
Journal:  Neuro Oncol       Date:  2011-02-04       Impact factor: 12.300

6.  Apparent diffusion coefficient histogram analysis stratifies progression-free survival in newly diagnosed bevacizumab-treated glioblastoma.

Authors:  W B Pope; A Lai; R Mehta; H J Kim; J Qiao; J R Young; X Xue; J Goldin; M S Brown; P L Nghiemphu; A Tran; T F Cloughesy
Journal:  AJNR Am J Neuroradiol       Date:  2011-02-17       Impact factor: 3.825

7.  Metrics and textural features of MRI diffusion to improve classification of pediatric posterior fossa tumors.

Authors:  D Rodriguez Gutierrez; A Awwad; L Meijer; M Manita; T Jaspan; R A Dineen; R G Grundy; D P Auer
Journal:  AJNR Am J Neuroradiol       Date:  2013-12-05       Impact factor: 3.825

Review 8.  FSL.

Authors:  Mark Jenkinson; Christian F Beckmann; Timothy E J Behrens; Mark W Woolrich; Stephen M Smith
Journal:  Neuroimage       Date:  2011-09-16       Impact factor: 6.556

9.  Histopathological spectrum of paediatric diffuse intrinsic pontine glioma: diagnostic and therapeutic implications.

Authors:  Pawel Buczkowicz; Ute Bartels; Eric Bouffet; Oren Becher; Cynthia Hawkins
Journal:  Acta Neuropathol       Date:  2014-07-22       Impact factor: 17.088

10.  Diffusion tensor histogram analysis of pediatric diffuse intrinsic pontine glioma.

Authors:  Emilie A Steffen-Smith; Joelle E Sarlls; Carlo Pierpaoli; Joanna H Shih; Robyn S Bent; Lindsay Walker; Katherine E Warren
Journal:  Biomed Res Int       Date:  2014-06-11       Impact factor: 3.411

View more
  29 in total

1.  Discrepant longitudinal volumetric and metabolic evolution of diffuse intrinsic Pontine gliomas during treatment: implications for current response assessment strategies.

Authors:  U Löbel; S Hwang; A Edwards; Y Li; X Li; A Broniscer; Z Patay
Journal:  Neuroradiology       Date:  2016-07-20       Impact factor: 2.804

2.  Volumetric voxelwise apparent diffusion coefficient histogram analysis for differentiation of the fourth ventricular tumors.

Authors:  Seyedmehdi Payabvash; Tarik Tihan; Soonmee Cha
Journal:  Neuroradiol J       Date:  2018-09-19

3.  A phase I/II study of veliparib (ABT-888) with radiation and temozolomide in newly diagnosed diffuse pontine glioma: a Pediatric Brain Tumor Consortium study.

Authors:  Patricia A Baxter; Jack M Su; Arzu Onar-Thomas; Catherine A Billups; Xiao-Nan Li; Tina Young Poussaint; Edward R Smith; Patrick Thompson; Adekunle Adesina; Pete Ansell; Vincent Giranda; Arnold Paulino; Lindsey Kilburn; Ibrahim Quaddoumi; Alberto Broniscer; Susan M Blaney; Ira J Dunkel; Maryam Fouladi
Journal:  Neuro Oncol       Date:  2020-06-09       Impact factor: 12.300

4.  Diffusion Characteristics of Pediatric Diffuse Midline Gliomas with Histone H3-K27M Mutation Using Apparent Diffusion Coefficient Histogram Analysis.

Authors:  M S Aboian; E Tong; D A Solomon; C Kline; A Gautam; A Vardapetyan; B Tamrazi; Y Li; C D Jordan; E Felton; B Weinberg; S Braunstein; S Mueller; S Cha
Journal:  AJNR Am J Neuroradiol       Date:  2019-11-06       Impact factor: 3.825

5.  MR imaging features of diffuse intrinsic pontine glioma and relationship to overall survival: report from the International DIPG Registry.

Authors:  James L Leach; James Roebker; Austin Schafer; Joshua Baugh; Brooklyn Chaney; Christine Fuller; Maryam Fouladi; Adam Lane; Renee Doughman; Rachid Drissi; Mariko DeWire-Schottmiller; David S Ziegler; Jane E Minturn; Jordan R Hansford; Stacie S Wang; Michelle Monje-Deisseroth; Paul G Fisher; Nicholas G Gottardo; Hetal Dholaria; Roger Packer; Katherine Warren; Sarah E S Leary; Stewart Goldman; Ute Bartels; Cynthia Hawkins; Blaise V Jones
Journal:  Neuro Oncol       Date:  2020-11-26       Impact factor: 12.300

6.  MR Imaging Correlates for Molecular and Mutational Analyses in Children with Diffuse Intrinsic Pontine Glioma.

Authors:  C Jaimes; S Vajapeyam; D Brown; P-C Kao; C Ma; L Greenspan; N Gupta; L Goumnerova; P Bandopahayay; F Dubois; N F Greenwald; T Zack; O Shapira; R Beroukhim; K L Ligon; S Chi; M W Kieran; K D Wright; T Y Poussaint
Journal:  AJNR Am J Neuroradiol       Date:  2020-05-07       Impact factor: 3.825

7.  Correlation of 18F-FDG PET and MRI Apparent Diffusion Coefficient Histogram Metrics with Survival in Diffuse Intrinsic Pontine Glioma: A Report from the Pediatric Brain Tumor Consortium.

Authors:  Katherine A Zukotynski; Sridhar Vajapeyam; Frederic H Fahey; Mehmet Kocak; Douglas Brown; Kelsey I Ricci; Arzu Onar-Thomas; Maryam Fouladi; Tina Young Poussaint
Journal:  J Nucl Med       Date:  2017-03-30       Impact factor: 10.057

8.  Quantifying radiation therapy response using apparent diffusion coefficient (ADC) parametric mapping of pediatric diffuse intrinsic pontine glioma: a report from the pediatric brain tumor consortium.

Authors:  Rafael Ceschin; Mehmet Kocak; Sridhar Vajapeyam; Ian F Pollack; Arzu Onar-Thomas; Ira J Dunkel; Tina Young Poussaint; Ashok Panigrahy
Journal:  J Neurooncol       Date:  2019-02-27       Impact factor: 4.130

9.  Increasing FLAIR signal intensity in the postoperative cavity predicts progression in gross-total resected high-grade gliomas.

Authors:  Guan-Min Quan; Yong-Li Zheng; Tao Yuan; Jian-Ming Lei
Journal:  J Neurooncol       Date:  2018-03-21       Impact factor: 4.130

10.  MRI Evaluation of Non-Necrotic T2-Hyperintense Foci in Pediatric Diffuse Intrinsic Pontine Glioma.

Authors:  O Clerk-Lamalice; W E Reddick; X Li; Y Li; A Edwards; J O Glass; Z Patay
Journal:  AJNR Am J Neuroradiol       Date:  2016-05-19       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.